Chemoinformaics analysis of (1S,2S,8R)-2,6,7,7-tetramethyltricyclo[6.2.1.01,5]undecane
| Molecular Weight | 206.373 | nRot | 0 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 13 |
| Exact Molecular Weight | 206.203 | nRing | 3 |
| Solubility: LogS | -6.144 | nHRing | 0 |
| Solubility: LogP | 5.192 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 42.3866 |
| nHD | 0 | BPOL | 26.0834 |
| QED | 0.547 |
| Synth | 5.363 |
| Natural Product Likeliness | 2.629 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.023 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.672 |
| MDCK | 0.0000151 |
| BBB | 0.804 |
| PPB | 0.968525 |
| VDSS | 1.795 |
| FU | 0.034034 |
| CYP1A2-inh | 0.212 |
| CYP1A2-sub | 0.595 |
| CYP2c19-inh | 0.306 |
| CYP2c19-sub | 0.948 |
| CYP2c9-inh | 0.422 |
| CYP2c9-sub | 0.768 |
| CYP2d6-inh | 0.053 |
| CYP2d6-sub | 0.859 |
| CYP3a4-inh | 0.386 |
| CYP3a4-sub | 0.317 |
| CL | 15.501 |
| T12 | 0.065 |
| hERG | 0.015 |
| Ames | 0.004 |
| ROA | 0.049 |
| SkinSen | 0.23 |
| Carcinogencity | 0.023 |
| EI | 0.961 |
| Respiratory | 0.783 |
| NR-Aromatase | 0.011 |
| Antiviral | Yes |
| Prediction | 0.928645 |